AbbVie
AbbVie is a global biopharmaceutical company that develops innovative medicines to solve complex health issues. With a strong focus on patient needs, research, and social responsibility, AbbVie improves the lives of millions worldwide.
AbbVie: A global biopharmaceutical company focused on innovation and patient needs
editAbout us
editAbbVie is a globally operating biopharmaceutical company that specializes in the development and delivery of innovative medicines and solutions to address complex health issues and improve people's lives. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie is headquartered in North Chicago, Illinois, USA[3][5].
Mission and values
editAbbVie's mission is to discover and deliver innovative medicines and solutions that improve people's lives. Every solution begins with the patient's perspective, as transformative medicines only have meaning when they are safe, effective, and accessible to all who need them. AbbVie is driven by compassion for people, a commitment to innovation and inclusion, service to the community, and unwavering integrity[1][3][4].
Key products and services
editAbbVie focuses on several key therapeutic areas, including immunology, oncology, neurology, ophthalmology, virology, and medical aesthetics. Among the most prominent products is adalimumab, marketed under the brand name Humira, which generated approximately 26 billion USD in revenue in 2023. Other important therapeutic areas include hepatitis C, rheumatoid arthritis, psoriasis, multiple sclerosis, Alzheimer's, Parkinson's, and multiple myeloma[4][5].
Research and development
editAbbVie operates extensive research and manufacturing sites worldwide, including in the USA, Germany, and other countries. The company collaborates closely with leading biotech firms, universities, non-profit organizations, and government agencies to advance scientific research. AbbVie has a robust pipeline of potential new medicines and is engaged in numerous collaborations, such as with Biogen and Principia Biopharma, to develop innovative therapies[1][4][5].
Sustainability and social responsibility
editAbbVie is strongly committed to sustainability goals and social responsibility. The company has initiated comprehensive initiatives to improve environmental, social justice, and corporate governance (ESG). AbbVie respects, protects, and fulfills the human rights of its employees and in its supply chains, emphasizing the importance of integrity in its business operations. Additionally, AbbVie employees raised over 12.6 million USD for 12,600 non-profit organizations worldwide in 2022[1][4].
Global presence and employees
editAbbVie has employees in over 70 countries and operates research and manufacturing sites worldwide. In Germany alone, the company has a headquarters in Wiesbaden, a large research and manufacturing site in Ludwigshafen, and a capital office in Berlin. Worldwide, AbbVie's products treat millions of people annually, and the company is committed to having a positive impact on healthcare, science, and local communities[1][4][5].
Conclusion
editAbbVie is a dynamic and innovative biopharmaceutical company distinguished by its patient focus, scientific excellence, and social responsibility. With a strong emphasis on research and development and a global presence, AbbVie works tirelessly to improve the lives of people worldwide.